NDC 50090-4376-01 - NP THYROID 30
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-4376
- Requested NDC
- 50090-4376-01
- Package NDCs from labels
- 50090-4376-1, 50090-4376-0, 50090-4376-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2024-01-21
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NP THYROID 30 - A-S Medication Solutions | A-S Medication Solutions | 2024-01-21 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4376-0 | 2023-02-07 | NP THYROID 30 |
| 50090-4376-1 | 2023-02-07 | NP THYROID 30 |
| 50090-4376-0 | 2023-01-30 | NP THYROID 30 |
| 50090-4376-1 | 2023-01-30 | NP THYROID 30 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4376-0 | NP THYROID 30 | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 50090-4376-1 | NP THYROID 30 | 90 in 1 BOTTLE | TABLET | 90 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4376 | NP THYROID 30 (LEVOTHYROXINE, LIOTHYRONINE) TABLET [A-S MEDICATION SOLUTIONS] | 9 | Current NDC, Legacy NDC, 2 package rows | 20240123_9e16caea-814f-4972-a8f4-d19b07a3d1a0.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4376-1 | EA - Each | 50090-4376 | f0c965d2-ab96-4a94-a4b2-19099d5b7849 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glucose and Sodium Chloride | DEXTROSE ANHYDROUS AND SODIUM CHLORIDE | Baxter Healthcare Corporation | 1ba918d0-13d0-48bc-8742-658fc0eb47b6 | 2025-01-24 | LX22YL083G | |
| Anticoagulant Citrate Dextrose A ACD-A | ANTICOAGULANT CITRATE DEXTROSE A ACD-A | Arteriocyte Medical Systems, Inc. | b850deac-161f-4bb0-ac7f-bceac2a230c0 | 2025-01-23 | LX22YL083G | |
| ACD A | DEXTROSE MONOHYDRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | Terumo BCT Ltd | 570770de-9b48-4fc1-a1ee-06002ca9504f | 2025-01-22 | LX22YL083G | |
| Anticoagulant Citrate Dextrose (ACD-A) | DEXTROSE MONOHYDRATE, SODIUM CITRATE, UNSPECIFIED FORM, AND CITRIC ACID MONOHYDRATE | Terumo BCT, Ltd | 0130d7c8-d067-4528-beb7-166559c33be9 | 2025-01-21 | Warnings, Adverse reactions | LX22YL083G |
| NP THYROID 60 | LEVOTHYROXINE LIOTHYRONINE | DIRECT RX | c20f4ab2-8dbd-b83f-e053-2995a90a52db | 2025-01-20 | Warnings, Adverse reactions | 1724439 313387 06LU7C9H1V Q51BO43MG4 |
| Sunmark Mineral Oil Laxative | MINERAL OIL | Strategic Sourcing Services | c54f7df2-3845-425f-b13e-3dc000123f3c | 2025-01-14 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Chain Drug Marketing Association Inc. | 2b490a08-149d-76ab-e063-6394a90a084f | 2025-01-09 | Warnings | T5L8T28FGP |
| ARMOUR THYROID | THYROID, PORCINE | A-S Medication Solutions | f5a1ce3b-9c62-48da-9ad1-5fe771ae8ccb | 2025-01-09 | Boxed warning, Warnings, Adverse reactions | 313387 |
| Mineral Oil | MINERAL OIL | Safecor Health, LLC | ef182484-692e-4eb3-bcf1-3c990ec0d08e | 2025-01-08 | Warnings | T5L8T28FGP |
| Thyro Support | SARCOLACTICUM ACIDUM, VISCUM ALBUM, IODIUM, FUCUS VESICULOSUS, GALIUM APARINE, NATRUM OXALACETICUM, THYROIDINUM (SUIS), DHEA (DEHYDROEPIANDROSTERONE), PHENYL ISOTHIOCYANATE, TYRAMINE, ADENOSINUM TRIPHOSPHORICUM DINATRUM, ALPHA-KETOGLUTARICUM ACIDUM, FUMARICUM ACIDUM, MALICUM ACID, COLCHICUM AUTUMNALE, CONIUM MACULATUM, FUNICULUS UMBILICALIS SUIS, HEPAR SUIS, MEDULLA OSSIS SUIS, PINEAL GLAND (SUIS), SPLEEN (SUIS), THYMUS (SUIS), CALCAREA FLUORICA, PULSATILLA (PRATENSIS), SPONGIA TOSTA, CORTISONE ACETICUM, | Pro Weight Loss Inc. | 171e9798-35ac-498b-944e-0173c46188d7 | 2025-01-08 | Warnings | 06LU7C9H1V |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | LX22YL083G |
| Lubricant Eye PM | MINERAL OIL, WHITE PETROLATUM | Reliable 1 Laboratories LLC | baec8045-97fe-6f60-e053-2a95a90a050e | 2024-12-31 | Warnings | T5L8T28FGP |
| AD Medicated Rash | AD MEDICATED RASH | WellSpring Pharmaceutical Corporation | aac345bf-ea66-4f5b-a497-c24ea72f93ea | 2024-12-27 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Pharmacy Value Alliance, LLC | 3803a61b-308a-14a9-e054-00144ff88e88 | 2024-12-20 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c50cc6ad-e8a0-47c1-e053-2a95a90a4de6 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | fe18fa61-83f9-8bf9-e053-6294a90a7585 | 2024-12-18 | Warnings | T5L8T28FGP |
| HemorrhoidalOintment | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Trifecta Pharmaceuticals USA LLC | c59dcb2a-392b-670b-e053-2995a90a9682 | 2024-12-18 | Warnings | T5L8T28FGP |
| TheraCare Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Veridian Healthcare | fab95657-d257-e671-e053-6294a90a59e0 | 2024-12-18 | Warnings | T5L8T28FGP |
| Recticare Advanced | LIDOCAINE AND MINERAL OIL AND PHENYLEPHRINE HCL AND WHITE PETROLATUM | Ferndale Laboratories, Inc. | 209212a7-7b6e-4b26-9f31-0eeb76f026bf | 2024-12-17 | Warnings | T5L8T28FGP |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCI | Rugby | a5b5e0a9-eee9-2a1e-e053-2a95a90a464e | 2024-12-17 | Warnings | T5L8T28FGP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.